Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 60,653 | 56,383 | 64,730 | 22,311 | 22,195 |
| Gross Profit | 60,653 | 56,383 | 64,730 | 22,311 | 22,195 |
| Operating Expenses | 80,272 | 72,294 | 77,183 | 60,978 | 52,799 |
| Operating Income | -19,619 | -15,911 | -12,453 | -38,667 | -30,604 |
| Interest Expense | 2,674 | 3,011 | 3,010 | 3,011 | 3,011 |
| Other Income | 3,604 | 7,304 | 1,473 | 5,840 | 6,841 |
| Pre-tax Income | -18,689 | -11,618 | -13,990 | -35,838 | -26,774 |
| Net Income Continuous | -18,689 | -11,618 | -13,990 | -35,838 | -26,774 |
| Net Income | $-18,689 | $-11,618 | $-13,990 | $-35,838 | $-26,774 |
| EPS Basic Total Ops | -0.24 | -0.15 | -0.20 | -0.54 | -0.41 |
| EPS Basic Continuous Ops | -0.24 | -0.15 | -0.20 | -0.54 | -0.41 |
| EPS Diluted Total Ops | -0.24 | -0.15 | -0.20 | -0.54 | -0.41 |
| EPS Diluted Continuous Ops | -0.24 | -0.15 | -0.20 | -0.54 | -0.41 |
| EBITDA(a) | $-16,678 | $-12,965 | $-9,554 | $-35,808 | $-27,730 |